New ways to help people with macular degeneration improve their eye movement strategies
New methods to quantify and train eye movement strategies in macular degeneration
This study is exploring a new way to help people with macular degeneration learn to see better by training them to use their side vision to work around blind spots, using special tools that mimic these spots to help them practice.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Riverside NIH-funded |
| Lab location | 1 site (Riverside, United States) |
| Project ID | NIH-10551330 on NIH RePORTER |
What this research studies
This research investigates a novel approach to assist individuals with macular degeneration (MD) by enhancing their awareness of scotomas, or blind spots in their vision. The study aims to train patients to develop new fixation points in their peripheral vision to compensate for central vision loss. By utilizing gaze-contingent displays that simulate scotomas, researchers hope to accelerate the development of these new fixation strategies, which can lead to improved visual function. The project will also analyze individual eye movement patterns to create personalized rehabilitation strategies for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with macular degeneration who experience central vision loss.
Not a fit: Patients with other forms of vision impairment unrelated to macular degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the visual capabilities and quality of life for patients with macular degeneration.
How similar studies have performed: Previous studies have shown success in using gaze-contingent displays to enhance visual strategies in healthy participants, suggesting potential for similar benefits in macular degeneration patients.
Where this research is happening
Riverside, United States
- University of California Riverside — Riverside, United States (Active)
Researchers
- Principal investigator: Maniglia, Marcello — University of California Riverside
- Study coordinator: Maniglia, Marcello
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.